Announcements

A Study on the Impact of the COVID-19 Pandemic on Pediatric Oncology Providers Globally

 

Coronavirus disease 2019 (COVID-19) disrupted pediatric oncology care globally, increasing demands on health care providers (HCPs) who adapted to continue care. Elizabeth R. Sniderman, et al. sought to characterize the pandemic's impact on pediatric oncology HCPs worldwide. Result shows that COVID-19 had a profound impact on the pediatric oncology workforce, creating challenging modifications to staffing and resulting in physical, psychological, and financial distress. Despite these challenges, HCPs caring for children with cancer came together to continue to provide high-quality care. More details, please click here.

Figure 1. Survey respondents and focus-group institutions. Countries represented by survey respondents (green, categorized by country income classification) and focus groups. Responses were received from 79 countries; focus groups were held in 16 countries.

 
Posted: 2022-02-10 More...
 

Updated Lung Cancer Screening Guidelines

 

When it comes to lung cancer, the statistics are grim. Only 15 percent of patients are still alive five years after diagnosis because symptoms often don’t appear until later stages, and about 70 percent of people have advanced disease at the time they’re diagnosed, according to a study published in February 2020 in The New England Journal of Medicine (NEJM).

Figure 1The new, broader, lung cancer screening guidelines make it easier for women and Black Americans to be eligible for lung cancer screening. @ Getty Images

 
Posted: 2021-09-23 More...
 

Meet One of Our Editors-in-Chief

 


Prof. Jun Chen

Department of Neurology, Pittsburgh Institute of Brain Disorders and Recovery, University of Pittsburgh
United States
 

 
Posted: 2021-05-14 More...
 

Cancer+ Renamed as Cancer Plus

 

Starting March 2021, Cancer+ will be officially renamed as Cancer Plus. All articles that are assigned to Volume 3 Issue 2 (2021) and thereafter will be published under the new journal title—Cancer Plus. This is for increasing the visibility of the journal on the Internet. Specifically, the plus sign “+” in the original journal title can hardly be recognized by many browsers, complicating the simple step of searching the journal online. For that reason, Whioce Publishing decided to make this change.

 
Posted: 2021-03-11 More...
 

A Commentary: Association of Repeatedly Heated Oil-Induced Hepatic Fat Accumulation and Development of Cancer

 

According to “Association of Repeatedly Heated Oil-Induced Hepatic Fat Accumulation and Development of Cancer”[1] and "Repeatedly Heated Mix Vegetable Oils-induced Atherosclerosis and Effects of Murraya koenigii"[2], long-term intake of repeatedly heated mix vegetable oils (RHMVO) leads to fat accumulation in hepatocytes, oxidative stress, and lipid peroxidation. Several studies have illustrated the negative effect of RHMVO on human health.

 
Posted: 2021-02-25 More...
 

One Editor’s New High-level Article is Published!

 

Figure 1. Computed tomography (CT) scan imaging. Panel (AC): 80-year-old male with metastatic non-small-cell lung cancer (mNSCLC) showing a classical cryptogenic organized pneumonia pattern. (A) Axial chest CT image obtained after 10 months of treatment with nivolumab showing multiple consolidations involving both lungs. (B) Axial follow-up CT-image obtained 1 month later showing an improvement of pneumonitis and the presence of ground-glass opacities. (C) Axial follow-up CT image obtained 11 months later showing pneumonitis resolution and the presence of bilateral fibrotic alteration. Panel (DE): 70-six-year-old male with mNSCLC presenting a not otherwise specified pattern of pneumonitis. (D) Axial chest CT image obtained 2 months after the beginning of the treatment with nivolumab showing multiple consolidations, interlobular septal thickening, subpleural reticulations. (E) Axial chest CT image obtained 8 months later showing a complete resolution of the signs.

 
Posted: 2020-09-14 More...
 

Results Shed Light on a New Mechanism for the Development of Endometrial Carcinoma

 

Chong Li is as Corresponding author to publish a paper titled “EM2D9, A monoclonal antibody against integrin α5β1, has potent antitumor activity on endometrial cancer in vitro and in vivo” on Cancer Letters.

 

Dr. Chong Li

One of Editors-in-Chief of Cancer+

Medical Immunodiagnostic Research Center, Institute of Biophysics, Chinese Academy of Sciences
China

 
Posted: 2020-06-15 More...
 

Final Vol. 1 No. 4 of 2019 is now live!

 

We are so pleased to announce that all the issues of 2019 is now live, and please click here for more details.

 
Posted: 2020-02-16 More...
 
1 - 8 of 8 Items